Two months after a National Company Law Tribunal (NCLT) issued an order initiating corporate insolvency proceedings against debt-ridden Orchid Pharma, numerous potential suitors, including top private equity players and domestic peers are eyeing the Chennai based company as part of a resolution plan under the provisions of the insolvency and bankruptcy code, multiple sources familiar with ongoing negotiations told ET NOW on the condition of anonymity.
” The resolution talks are at an early stage and the committee of creditors recently held their first meeting on October 3rd. There is considerable interest in the company amongst both private equity funds and strategic domestic players and the likes of KKR, the distressed asset platfor…
Read the full article at: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pe-funds-domestic-pharma-companies-eye-orchid-pharma-under-ibc/articleshow/61226640.cms